Related Experiment Video
Updated: May 30, 2025

The Goeckerman Regimen for the Treatment of Moderate to Severe Psoriasis
Published on: July 11, 2013
Pyoderma Gangrenosum Improved with Dapsone and Prednisone: A Case Report
Arbie Sofia P Merilleno1, Charlene Marie Ang-Tiu
1Arbie Sofia P. Merilleno, MD, DPDS, is an Inflammatory Disease Fellow, University of Toronto, Ontario, Canada; Clinical Fellow, Women's College Hospital, Ontario; and Research Fellow, Women's College Research Institute, Ontario. Charlene Marie Ang-Tiu, MD, FPDS, is Medical Specialist, Rizal Medical Center, Pasig City, Philippines. The authors have disclosed no financial relationships related to this article. Submitted November 11, 2023; accepted in revised form April 2, 2024.
Pyoderma gangrenosum, a rare ulcerative condition, can be effectively treated with a combination of prednisone and dapsone. This therapeutic approach led to complete resolution in a patient with long-standing, nonhealing ulcers.
Area of Science:
- Dermatology
- Immunology
Background:
- Pyoderma gangrenosum (PG) is a rare, chronic ulcerative condition.
- Diagnosis and management are challenging due to rarity and varied presentations.
- Delayed treatment can lead to significant morbidity.
Purpose of the Study:
- To report a case of pyoderma gangrenosum successfully treated with a combination therapy.
- To highlight an effective treatment strategy for recalcitrant cases.
Main Methods:
- A case report of a 36-year-old male patient with nonhealing ulcers.
- Treatment involved oral corticosteroids (prednisone) and dapsone.
- Response to therapy was monitored over six months.
Main Results:
- The patient presented with long-standing ulcers unresponsive to antibiotics and debridement.
- Combination therapy with prednisone and dapsone resulted in complete resolution of lesions.
- The treatment was well-tolerated over a 6-month period.
Conclusions:
- Combined prednisone and dapsone therapy can be a valuable option for pyoderma gangrenosum.
- This treatment approach may be particularly beneficial in resource-limited settings.
- Early diagnosis and appropriate management are crucial for favorable outcomes in PG.
Related Concept Videos
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Burn Injuries
The damage results in the death of skin cells, which can lead to a massive loss of fluid. Dehydration, electrolyte imbalance, and renal and circulatory failure follow, which can be fatal. Burn patients are treated with intravenous fluids to offset...
Skin Diseases and Disorders
Gram-positive Staphylococcus spp. and Streptococcus spp. are responsible for many of the most common skin infections. However, many...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

